{
    "clinical_study": {
        "@rank": "137950", 
        "acronym": "24Hr", 
        "biospec_descr": {
            "textblock": "Blood samples, adipose tissue samples and muscle samples"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this research study is to learn more about how our body produces sugar,\n      breaks down fat for fuel, and makes insulin (the major hormone that controls the production\n      of blood sugar and fat breakdown) during a 24-hour day and how body fat and muscle are\n      involved in these processes."
        }, 
        "brief_title": "Diurnal Variability in the Regulation of Beta-cell Function and Insulin Sensitivity in Overweight People", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Overweight", 
        "condition_browse": {
            "mesh_term": [
                "Overweight", 
                "Insulin Resistance"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to determine whether there are diurnal differences in\n      postprandial beta-cell function and hepatic insulin sensitivity and the factors that\n      influence these metabolic functions, including insulin signaling, adipose tissue and\n      systemic inflammation, nicotinamide phosphoribosyltransferase (NAMPT)-mediated nicotinamide\n      adenine dinucleotide(NAD) biosynthesis, and sirtuin (silent mating type information\n      regulation 2 homolog 1 (SIRT1)) in overweight human subjects."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Females\n\n          -  18-55 years old\n\n          -  BMI between 25.0-29.9 kg/m2\n\n          -  Must be sedentary (regular exercise <1hour/week or <2 times/week\n\n        Exclusion Criteria:\n\n          -  Regular exercise (>1hour/week or >2 times/week)\n\n          -  Diabetes\n\n          -  Severe organ dysfunction\n\n          -  Smokers\n\n          -  Severe hypertriglyceridemia (>300 mg/dl)\n\n          -  Medications that may alter the results of the study\n\n          -  Pregnant\n\n          -  Breastfeeding"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The study population will consist of female subjects of all races and ethnic groups.\n        Participants will be recruited by reviewing our database of research subjects containing\n        thousands of research study volunteers and by St. Louis metro area postings."
            }
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02011581", 
            "org_study_id": "2011-09110"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Overweight", 
        "lastchanged_date": "December 18, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "St. Louis", 
                    "country": "United States", 
                    "state": "Missouri", 
                    "zip": "63110"
                }, 
                "name": "Washington University School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Diurnal Variability in the Regulation of Beta-cell Function and Insulin Sensitivity in Overweight People", 
        "overall_official": {
            "affiliation": "Washington University School of Medicine", 
            "last_name": "Samuel Klein, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Postprandial pancreatic beta-cell function will be evaluated by using a mixed meal labelled with stable isotope tracers, in conjunction with stable isotope tracer infusion.  Metabolic outcomes from the breakfast meal will be compared with values obtained after dinner.", 
                "measure": "Determine postprandial beta-cell function (insulin secretion) after ingesting breakfast and dinner meals.", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Postprandial pancreatic hepatic insulin sensitivity will be evaluated by using a mixed meal labelled with stable isotope tracers, in conjunction with stable isotope tracer infusion.  Metabolic outcomes from the breakfast meal will be compared with values obtained after dinner.", 
                "measure": "Determine postprandial hepatic insulin sensitivity (suppression of endogenous glucose production) after ingesting breakfast and dinner meals.", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02011581"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "This muscle samples will be obtained two times (every 12 hours for 24 hours)to assess NAMPT and NAD+ concentrations, SIRT1 activity, and factors involved in insulin signaling.", 
                "measure": "Determine whether there is diurnal variability in muscle insulin signaling", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Subcutaneous adipose tissue samples will be obtained four times (every 6 hours for 24 hours) to evaluate NAMPT and NAD+ concentrations, SIRT1 activity, and markers of inflammation.", 
                "measure": "Determine whether there is diurnal variability in adipose tissue and systemic inflammation.", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Blood samples will be obtained at regular intervals for 24 hours to evaluate; 1)plasma free fatty acids (FFA), glucose and insulin concentrations, 2)NAMPT and NAD+ concentrations, 3)SIRT1 activity,and 4)systemic markers of inflammation (C-reactive protein and interleukin (IL) -6).", 
                "measure": "Determine whether there is diurnal variability in NAMPT-mediated NAD+ biosynthesis and SIRT1.", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }
        ], 
        "source": "Washington University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Washington University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}